CRM
50
-5
TXT
58
-2
FLS
46
-7
DOV
63
-6
SWN
70
3
CCI
36
-5
EA
44
-2
PNR
72
-2
FTI
69
-7
HPE
53
2
NSC
62
2
MS
50
-8
JPM
53
-2
O
35
-2
EBAY
50
-3
PSX
42
3
WYNN
34
-3
SYK
57
-2
PWR
60
-2
CNX
76
5
CRM
50
-5
TXT
58
-2
FLS
46
-7
DOV
63
-6
SWN
70
3
CCI
36
-5
EA
44
-2
PNR
72
-2
FTI
69
-7
HPE
53
2
NSC
62
2
MS
50
-8
JPM
53
-2
O
35
-2
EBAY
50
-3
PSX
42
3
WYNN
34
-3
SYK
57
-2
PWR
60
-2
CNX
76
5
Financhill
Back

Mereo BioPharma Group PLC Quote, Financials, Valuation and Earnings

"The Next Apple?" - Mode's Growth Story is Turning Heads

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56

MREO
Mereo BioPharma Group PLC

Last Price:
4.28
Seasonality Move:
-19.59%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Tech Giant in Your Pocket?

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Mereo BioPharma Group PLC Price Quote

$4.28
+0.00 (+1.42%)
(Updated: September 20, 2024 at 4:04 AM ET)

Mereo BioPharma Group PLC Key Stats

Buy
56
Mereo BioPharma Group PLC (MREO) is a Buy
Day range:
$4.24 - $4.44
52-week range:
$1.07 - $5.02
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
8.36%
Volume:
714.4K
Avg. volume:
958K
1-year change:
190.82%
Market cap:
$657.7M
Revenue:
$10M
EPS:
$-0.26

How Much Does Mereo BioPharma Group PLC Make?

Data Unavailable

Is Mereo BioPharma Group PLC Growing As A Company?

Data Unavailable

Mereo BioPharma Group PLC Stock Price Performance

What Is Mereo BioPharma Group PLC 52-Week High & Low?

Mereo BioPharma Group PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Mereo BioPharma Group PLC?

Is Mereo BioPharma Group PLC Cash Flow Positive?

  • What Is MREO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$32.9M
  • What Is Mereo BioPharma Group PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Mereo BioPharma Group PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.1M

Mereo BioPharma Group PLC Return On Invested Capital

Data Unavailable

Mereo BioPharma Group PLC Earnings Date & Stock Price

Mereo BioPharma Group PLC Competitors

Mereo BioPharma Group PLC Dividend Yield

Mereo BioPharma Group PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -97.31%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.38
Upside from Last Price: 72.71%

Major Shareholders

  • How many MREO shares are owned by institutional investors?
    104.6M MREO shares are owned by institutional investors
  • How many MREO shares are owned by insiders?
    4.5M MREO shares are owned by insiders